Incidental PET/CT findings in the cancer patient: How should they be managed?-Reference-Cited by-同舟云学术

Incidental PET/CT findings in the cancer patient: How should they be managed?

Published:2009-08 Issue:2 Volume:146 Page:274-281
ISSN:0039-6060
Container-title:Surgery
language:en
Short-container-title:Surgery

Author:

Beatty John S.,Williams Hadyn T.,Aldridge Beau A.,Hughes Matthew P.,Vasudeva Viren S.,Gucwa Angela L.,David George S.,Lind D. Scott,Kruse E. James,McLoughlin James M.

Publisher

Elsevier BV

Subject

Surgery

Reference31 articles.

1. Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology;Antoch;JAMA,2003

2. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada;Therasse;J Natl Cancer Inst,2000

3. Oncological applications of FDG PET imaging;Delbeke;J Nucl Med,1999

4. Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer;Swisher;Ann Thorac Surg,2004

5. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1);Eisenhauer;Eur J Cancer,2009

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer in Patients With Incidental Asymmetric Oropharynx Positron Emission Tomography Uptake;JAMA Otolaryngology–Head & Neck Surgery;2024-08-29

2. Clinical implications of non-breast cancer related findings on FDG-PET/CT scan prior to neoadjuvant chemotherapy in patients with breast cancer;Breast Cancer Research and Treatment;2024-06-12

3. False Liver Metastasis by Positron Emission Tomography/Computed Tomography Scan after Chemoradiotherapy for Esophageal Cancer—Potential Overstaged Pitfalls of Treatment;Cancers;2024-02-26

4. Breast incidentalomas on 18‐ F luorodeoxyglucose positron emission tomography‐computed tomography performed for a non‐mammary cause: Significance and outcomes;Journal of Medical Imaging and Radiation Oncology;2022-12-05

5. Risk of Second Primary Malignancies Associated with Radioactive Iodine Treatment in Young Patients with Thyroid Cancer;Clinical Thyroidology;2022-04-01